OKYO Pharma Ltd

LSE:OKYO (UK)  
£ 0.02 (-12.5%) May 10
At Loss
Market Cap:
£ 34.84M ($ 44.49M)
Enterprise V:
£ 34.20M ($ 43.69M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset -3.82
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -18.2
3-Year EPS without NRI Growth Rate -21.3
3-Year FCF Growth Rate -27.7

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -36.36
12-1 Month Momentum % -71.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.21
Quick Ratio 0.21
Cash Ratio 0.11

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -47.7
Shareholder Yield % -26.37

Profitability Rank

Name Current Vs Industry Vs History
ROA % -393.54
ROIC % -1184.28
ROC (Joel Greenblatt) % -263740

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -2.58
EV-to-EBITDA -2.58
EV-to-FCF -4.42
Earnings Yield (Greenblatt) % -38.76
FCF Yield % -21.47

Financials (Next Earnings Date:2025-03-28 Est.)

LSE:OKYO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

OKYO Pharma Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £)
EPS (TTM) (£) -0.003
Beta 0
Volatility % 80.46
14-Day RSI 0
14-Day ATR (£) 0.003059
20-Day SMA (£) 0
12-1 Month Momentum % -71.43
52-Week Range (£) 0.0135 - 0.085
Shares Outstanding (Mil) 1,658.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

OKYO Pharma Ltd Filings

Filing Date Document Date Form
No Filing Data

OKYO Pharma Ltd Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

OKYO Pharma Ltd Frequently Asked Questions

What is OKYO Pharma Ltd(LSE:OKYO)'s stock price today?
The current price of LSE:OKYO is £0.02. The 52 week high of LSE:OKYO is £0.09 and 52 week low is £0.01.
When is next earnings date of OKYO Pharma Ltd(LSE:OKYO)?
The next earnings date of OKYO Pharma Ltd(LSE:OKYO) is 2025-03-28 Est..
Does OKYO Pharma Ltd(LSE:OKYO) pay dividends? If so, how much?
OKYO Pharma Ltd(LSE:OKYO) does not pay dividend.

Press Release

Subject Date
No Press Release